Related Experiment Videos
Dipeptidyl peptidase IV is down-regulated in rat hepatoma cells at the mRNA level
G W McCaughan1, C L Siah, C Abbott
1A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Abstract:
Dipeptidyl peptidase IV (DPP-IV) is a cell surface ectopeptidase that has been implicated in cell-extracellular matrix interactions, lymphocyte growth and the regulation of biological peptides. Previous studies have shown that immunostaining for DPP-IV and DPP-IV enzyme levels is decreased in hepatoma cells and levels have been correlated with the ability of such cells to adhere in vitro. The aim of this paper was to measure DPP-IV enzyme levels in rat hepatoma cells and to examine whether changes were associated with alterations at the mRNA level. The results indicate a greater than 90% reduction in DPP-IV enzyme levels in two rat hepatoma cell lines, HTC and H35, compared with rat hepatocytes. Enzyme levels of the control enzyme leucine aminopeptidase (LAP) were not decreased. mRNA studies indicated that these changes were associated with similar reductions in rat DPP-IV mRNA. It is concluded that DPP-IV is markedly reduced at the protein, enzyme and mRNA levels in rat hepatoma cells. The significance of these changes is unclear but may lead to decreased extracellular matrix interactions by such cells.
Insights
Dipeptidyl peptidase IV (DPP-IV) enzyme and mRNA levels are significantly reduced in rat hepatoma cells. This reduction may impact cell-extracellular matrix interactions.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Dipeptidyl peptidase IV (DPP-IV) is a cell surface ectopeptidase involved in various biological processes.
- Previous research suggests decreased DPP-IV levels and activity in hepatoma cells, correlating with reduced cell adhesion.
- The precise molecular mechanisms underlying these changes in hepatoma remain to be fully elucidated.
Purpose of the Study:
- To quantify DPP-IV enzyme levels in rat hepatoma cell lines.
- To investigate the correlation between DPP-IV enzyme levels and corresponding mRNA expression.
- To compare DPP-IV levels in hepatoma cells with normal rat hepatocytes.
Main Methods:
- Enzyme activity assays were performed on rat hepatoma cell lines (HTC and H35) and rat hepatocytes.
- Leucine aminopeptidase (LAP) was used as a control enzyme.
- Quantitative analysis of DPP-IV mRNA levels was conducted using molecular biology techniques.
Main Results:
- Rat hepatoma cell lines exhibited a greater than 90% reduction in DPP-IV enzyme activity compared to normal hepatocytes.
- Levels of the control enzyme LAP remained unchanged in hepatoma cells.
- A corresponding significant reduction in DPP-IV mRNA levels was observed in hepatoma cells, mirroring the protein and enzyme level changes.
Conclusions:
- Dipeptidyl peptidase IV (DPP-IV) expression is markedly downregulated at the protein, enzyme, and mRNA levels in rat hepatoma cells.
- The observed reduction in DPP-IV may contribute to altered cell-extracellular matrix interactions in hepatoma.
- Further research is warranted to understand the functional implications of DPP-IV downregulation in hepatoma progression.